Typical OTC under delivering mgmt leaching into nvestors

New Post Public Reply Private Reply Replies (1) Message Board
aidenb
580
Typical OTC under delivering mgmt leaching into nvestors pocket.
They know they are not having revenue until 2021.
I wouldn't mind giving that to Patterson alone for has corp months ago.

We are taking the suckers choice... Keeping up with Thai BS.

Nader is a smart guy.. The way Iranian leaders do it is like. We get 25 ... Okay we reduced to 20 so everyone is happy.. At the rand they say we didn't know we took 35. Okay we take 10 less in our 2022 round which we projected 50 as we are still not selling....
FDA are bad. We don't suck.
2

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lessons from Warren Buffett: The Power of Long-Term Investing

Updated Category News Views 411

Understanding Warren Buffett's Investment Philosophy In a candid interview with financial journalist Adam Smith, Warren Buffett revealed the guiding principles behind his remarkable investment journey. Buffett, renowned for his down-to-earth demeanor, acknowledged that investing isn't just about numbers. He pointed out that a modest contribution of $10,000 into Berkshire...

Continue Reading
Allot Ltd. Reports Impressive Growth in Q3 Financials

Updated Category News Views 173

Allot Reports Third Quarter Financial Results 60% YoY SECaaS ARR growth alongside strong profitability; adjusting revenue forecast upward. Allot Ltd. (NASDAQ: ALLT), a prominent provider of Security-as-a-Service (SECaaS) and network intelligence solutions, has released its financial results for the third quarter of 2025, showcasing a remarkable performance driven by...

Continue Reading
Lixte Biotechnology's Path to Nasdaq Compliance and Growth

Updated Category News Views 77

Lixte Biotechnology Faces Nasdaq Compliance Challenge Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) is actively addressing its compliance with Nasdaq's stockholders' equity requirements. Following an SEC filing, the pharmaceutical company received a vital extension, providing them additional time to enhance their financial standings. Previously, Nasdaq had flagged...

Continue Reading
Challenge4Trading Introduces Innovative Trading Academy Online

Updated Category News Views 458

Challenge4Trading Launches a New Trading Academy Challenge4Trading proudly announces the launch of its comprehensive Trading Academy, an innovative e-learning platform designed to educate and support traders worldwide. The academy is now live and offers a vast library of dozens of video tutorials encompassing several hours of professional training content. It's tailored...

Continue Reading
Exploring Recent Trends in Vistra's Options Activity

Updated Category News Views 195

Market Giants Make Bold Moves with Vistra's Future Recent activity in options trading has shown a pronounced bullish outlook for Vistra Energy. Our review of Vistra's trading history uncovered a remarkable 96 unusual trades, signaling strong interest from both financial institutions and individual traders. When we break down the trading patterns, we find that 41% of...

Continue Reading